Patent · US Active

Factor XII inhibitors for treating interstitial lung disease

US9150638B2 · kind B2 · utility

0Cited by

9References

24Claims

0Family size

Assignee

JUSTUS-LIEBIG-UNIVERSITAET GIESSEN · DE

Inventors

Ewa Jablonska · Radłów, PL
Klaus Preissner · Gießen, DE
Malgorzata Wygrecka · Gießen, DE

Key dates

Filing date	Apr 1, 2011
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Apr 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.